Slovakian sprinter Ľuboš Križko has been banned for two years by FINA, after testing positive for a metabolite of Tamoxifen at the European championships in Budapest on August 12, 2010. Tamoxifen is the standard anti-estrogen therapy used to treat breast cancer patients, but is also used in doping to control the side effects of taking steroids. Read SwimNews.com.
Leave a Reply